Search
Immatics NV
IMTXAdd to Watchlist
9.950USD
+0.100+1.02%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
1.21BMarket Cap
LossP/E TTM
Immatics NV's Company Valuation
Currency: USD Updated: 2026-07-01The current valuation score of Immatics NV is 7.17, ranking 254 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -13.03, which is -509.65% below the recent high of 53.38 and -233.02% above the recent low of -43.40.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.